Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Appointed director
|
Aclaris Therapeutics, Inc. (ACRS)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/07/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
05/08/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
11/08/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
08/03/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
05/10/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
11/02/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
08/05/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
05/07/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
11/04/2020 |
10-Q
| Quarterly Report for the period ended September 30, 2020 |
08/07/2020 |
10-Q
| Quarterly Report for the period ended June 30, 2020 |
05/07/2020 |
10-Q
| Quarterly Report for the period ended March 31, 2020 |
11/07/2019 |
10-Q
| Quarterly Report for the period ended September 30, 2019 |
08/08/2019 |
10-Q
| Quarterly Report for the period ended June 30, 2019 |
05/08/2019 |
10-Q
| Quarterly Report for the period ended March 31, 2019 |
11/06/2018 |
10-Q
| Quarterly Report for the period ended September 30, 2018 |
08/03/2018 |
10-Q
| Quarterly Report for the period ended June 30, 2018 |
05/08/2018 |
10-Q
| Quarterly Report for the period ended March 31, 2018 |
11/07/2017 |
10-Q
| Quarterly Report for the period ended September 30, 2017 |
08/08/2017 |
10-Q
| Quarterly Report for the period ended June 30, 2017 |
05/09/2017 |
10-Q
| Quarterly Report for the period ended March 31, 2017 |
11/03/2016 |
10-Q
| Quarterly Report for the period ended September 30, 2016 |
08/11/2016 |
10-Q
| Quarterly Report for the period ended June 30, 2016 |
05/11/2016 |
10-Q
| Quarterly Report for the period ended March 31, 2016 |
11/18/2015 |
10-Q
| Quarterly Report for the period ended September 30, 2015 |
|
|